HolmesAI makes a world where
diseases are controlled.

Using data to outpace disease.

Driven by clinical data and AI algorithms, the HolmesAI delivers interventions personalized to the individual and their disease.
For all aspects of diagnosis-treatment and healthcare, the HolmesAI helps make care simpler, science smarter, and patients healthier.

DATA

TREATMENT

CARE

DIAGNOSIS

HolmesAI is a powerful and scalable AIoMT* company for heart disease.

* AIoMT : Artificial Intelligence Internet of Medical Things

Bringing the power of AI to cardiac

CLholmes® is the most innovative cardiac health management platform that predicts potential cardiac arrhythmia 6 months in advance.

Experience full access cardiac monitoring

Its patented AI prediction technology, the Component Aware Transformer, to analyze data, identifying over 21 heart patterns with cardiologist-level accuracy.

Any time, Any where

SmartPatch provides the world-class and only cardiac monitoring technology that monitors 4 significant vital signals and analyzes 21 cardiac arrhythmias simultaneously.

CLholmes® is a leading heart health management platform that
integrates cutting-edge AI with smart wearable technology.

Any time! Any where! Any device!

CLholmes® is the most innovative cardiac health management platform that predicts potential cardiac arrhythmia 6 months in advance. SmartPatch of CLholmes® that simultaneously monitors 4 vital signals and applies proprietary AI technology not only diagnoses 21 cardiac arrhythmias with cardiologist-level accuracy but also supports the development of appropriate preventative plans through early prediction of cardiac arrhythmias onset.

Additionally, CLholmes®’s chatbot based on GPT-4, can offer personalized services like consultations aligned with international treatment guidelines, lifestyle recommendations, and emergency alerts. This empowers individuals in remote regions and underdeveloped nations to predict their heart health in their daily lives proactively.

Health and Human Security

CLholmes® enhances human security by improving healthcare access, especially in medically underserved regions. According to the World Health Organization(WHO), 75% of heart disease cases occur in low and middle-income countries.

Health security is an important dimension of human security, as good health is “both essential and instrumental to human survival, livelihood and dignity”. An ageing population tends to have a higher prevalence of chronic diseases, physical disabilities, mental illnesses and other co-morbidities.

As heart disease is a leading cause of death globally, our technology's early detection capability is crucial for individual health protection and offers substantial economic benefits. By identifying heart issues early, HolmesAI helps avoid expensive treatments and reduces healthcare costs, significantly lowering national mortality rates and contributing to overall public health improvement.

Certification Patents Science Awards

We have won a number of certifications for our unrivalled science and expertise, and for the innovative thinking that goes into our technology.

AI R&D Center
ISO13485
ISO9001
Venture
(Innovative Growth Types)
Medical device manufacturing

Developing the AI-powered technology for monitoring physiological data in Korea, HolmesAI seeks to expand globally, with various patents already been granted in the U.S. and Asia.

KR - 10-2635642
KR - 10-2626602
PCT2024 / 095614
C-2024-017853

Backed by over a decade of R&D, the HolmesAI Team has published papers in SCI-indexed journals focused on cardiology and biomedical engineering. We have cooperated medical institutions and cardiologists for data collection and further improvement.

npj : Scientific reports. A novel hybrid CNN-transformer model for arrhythmia detection without R-peak identification using stockwell transform
Sensors. Assessment of ROI Selection for Facial Video-Based rPPG
applied sciences. Methods for Improving Deep Learning-Based Cardiac Auscultation Accuracy: Data Augmentation and Data Generalization

CES2025 Innovation Awards

CES2025 Accessibility & AgeTech, “Honoree”

HolmesAI CLholmes Honored with Innovation Award Honoree at CES 2025 HolmesAI CLholmes, the first AI-powered AIoMT Platform for cardiac health assessments developed by HolmesAI Corp., has been honored with the Innovation Award Honoree in the Accessibility & Age Tech category at CES 2025.

Partnerships

It’s the partnerships that make the difference. At HolmesAI, we are committed to building working relationships throughout the university hospital,pharmaceutical, and overseas medical company sectors as we fight against diseases.